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Abstract
Sequencing by synthesis is the underlying technology for many next-
generation DNA sequencing platforms. We developed a new model, the
fixed flow cycle model, to derive the distributions of sequence length for
a given number of flow cycles under the general conditions where the nu-
cleotide incorporation is probabilistic and may be incomplete, as in some
single-molecule sequencing technologies. Unlike the previous model, the
new model yields the probability distribution for the sequence length. Ex-
plicit closed form formulas are derived for the mean and variance of the
distribution.
1 Introduction
The next-generation sequencing (NGS) technology has transformed biology and
biomedical research by generating huge amount of sequence data at unprece-
dented speed. The emerging DNA sequencing technology also gave rise to many
interesting mathematical and statistical problems. One of these problems is the
statistical distributions of various quantities associated with sequencing by syn-
thesis (SBS) technology. Besides its practical applications in different stages in
the development and use of NGS technology, such as instrument development and
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testing, algorithm and software development, as well as daily monitoring of se-
quencing outputs, the problem is an interesting self-contained mathematical prob-
lem.
Unlike the traditional Sanger capillary electrophoresis method using dideoxynu-
cleotide chain-termination, many of the currently available platforms and those
that are still under development utilize SBS technology. In SBS platforms, nu-
cleotides are added to the reactions repeatedly in a pre-determined cyclic manner.
In a particular nucleotide cycle, if the added nucleotide is complementary to the
base in the template (the DNA to be sequenced), then the nucleotide will be poten-
tially synthesized by the enzyme (DNA polymerase) and a signal can be detected.
Since we know what nucleotide is added in that cycle, the base in the template can
be determined. If the dispensed nucleotide is not complementary to the base in the
template, or due to the probabilistic nature of the enzymatic synthesis reaction (see
subsection 1.1.2 below), the nucleotide will not be incorporated in this nucleotide
cycle. Apparently, the length of sequence that can be read from the DNA template
is not a linear function of the number of nucleotide cycles but rather depends on
the sequence context, the nucleotide flow order, and the reaction conditions that
determine the nucleotide incorporation probabilities.
We have studied the sequence length distributions of SBS previously (Kong,
2009a,b). There the problem was approached indirectly. In that model (see sub-
section 1.2.1 below) we fixed the sequence length and the probability distribution
obtained is actually the distribution of flow cycle for a given sequence length. It
would be more interesting to obtain directly the distribution of sequence length
for a given flow cycle. In the previous work we did obtain the sequence length
distribution, but that had to be done by using some approximate normalization. In
this paper we developed a new model, the fixed sequence length model (FSLM),
from which we obtain directly the sequence length distribution at a given flow
cycle. This model is more natural than the previous model as it allows for exact
computation of the associated probability distribution, while the previous model
only yielded approximations. Furthermore, the new model will be the basis on
which other statistical quantities of SBS platforms will be investigated in future
studies.
In subsection 1.2 the old and new models are to be discussed. Before that,
some basics of SBS technology will first be introduced. After this introduction
section, the complete and incomplete nucleotide incorporation cases will be stud-
ied in section 2 and section 3 respectively. The main results are Eqs. (19), (20), and
(21) for the general incomplete nucleotide incorporation conditions, with Eqs. (7),
(9) and (10) as their special cases for complete nucleotide incorporation condi-
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tions.
1.1 SBS technology
As mentioned earlier, SBS technology adds four nucleotides A, C, G, and T re-
peatedly in a pre-determined order. To avoid the unnecessary specification of the
detailed names of the four kinds of nucleotides, in the following we will use a, b,
c, and d to represent any permutations of the usual nucleotides A, C, G, and T , as
we did previously.
We call each of the four cycles where nucleotides are added a nucleotide cycle.
A flow cycle is defined as the “quad cycle” of successive four nucleotides cycles of
{abcd}, with “a” the first nucleotide in the flow cycle and “d” the last nucleotide
in the same flow cycle.
SBS reads the template DNA by synthesizing the base that is complementary
to the current base to be read in the template DNA. Nucleotide A is complemen-
tary to T , and C to G. After the complementary nucleotide is incorporated, certain
kind of signal can be detected, usually through fluorescence dye attached to the
incorporated nucleotide. The detected signal is registered with the pre-determined
nucleotide cycle, so the nature of the incorporated nucleotide can be determined.
Ideally, if we ignore noises and errors, and if the added nucleotide is not comple-
mentary to the base in the template DNA, then in that nucleotide cycle no signal
will be created. If the added nucleotide is complementary to the template, how-
ever, we have two possibilities, depending on what kind of NGS technology we
are dealing with. In the following we discuss two variations of SBS technolo-
gies, bulk sequencing and single-molecule sequencing, and the different degree of
completeness of nucleotide incorporation associated with the two technologies.
1.1.1 Bulk SBS and complete nucleotide incorporation
For bulk SBS sequencing technologies such as pyrosequencing, the template DNAs
go through a clonal amplification step before sequencing. What gets sequenced
is actually a collection of identical template molecules. During the sequencing
process, the synchronization between identical individual templates will be lost
gradually, leading to signal decay and sequencing errors. To avoid this dephasing
problem, the reaction reagents and synthesis chemistry are usually tuned to drive
the enzymatic incorporation to completion at each nucleotide cycle. Not only will
a single base, if it is complementary to the template base, be incorporated, but
also a stretch of identical bases (homopolymers) will be synthesized in the same
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nucleotide cycle. For example, if the template DNA has three G’s together, then
in one nucleotide cycle of C three nucleotides of C will be incorporated to match
each G in the template. In ideal conditions for complete nucleotide incorporation,
the sequence context and nucleotide flow order uniquely determine the emitted
signals.
For example, for sequence bddabaaad, with complete nucleotide incorpora-
tion the signal will be {0-1-0-2}-{1-1-0-0}-{3-0-0-1}, while for another sequence
abbbdabbc with the same length, the signal will be {1-3-0-1}-{1-2-1-0}, if we
assume that the strength of the signal is proportional to the number of nucleotides
incorporated in each nucleotide cycle (Table 1, Kong (2009a)). Here we use the
four numbers within the braces to indicate the signal strength of each nucleotide
cycle within a flow cycle. For example, the number 3 in the signal for the second
sequence (the second nucleotide cycle in the first flow cycle) corresponds to the
three consecutive b’s in the second sequence.
1.1.2 Single-molecule SBS and incomplete nucleotide incorporation
Some NGS platforms that have been commercially available recently or are under
active development utilize single-molecule DNA sequencing (SMS) technology.
Unlike the bulk sequencing platforms, SMS does not have a clonal amplification
step for the target sequences. Instead, a single target molecule is used as the tem-
plate. This avoids the problems of bias and errors introduced in the amplification
step. Another advantage of SMS is that the problem of dephasing associated with
bulk sequencing methods mentioned above does not exist for SMS. For this rea-
son, the reaction kinetics can be controlled to adjust the rate of nucleotide incorpo-
ration to the benefit of sequencing accuracy. For example, slow reaction kinetics
can be used deliberately to limit incorporation to two or three bases per nucleotide
cycle (Harris et al, 2008). For a homopolymer region GGG, bulk sequencing tech-
nology will try to incorporate three C’s in one nucleotide cycle; for SMS, however,
zero, one, two, or three C’s can be incorporated in a single synthesis cycle. This
flexibility in incorporation rate can be utilized to increase the resolution of ho-
mopolymer region. Under these conditions, even if the dispensed nucleotide for
a given cycle is complement to the base in the template, the nucleotide might
not be incorporated in the current nucleotide cycle. The incorporation of the nu-
cleotide may be delayed to the next cycle, or the next next cycle, and so on. Which
cycle the nucleotide will be incorporated will depend probabilistically on the re-
action conditions. Thus, the signal will not be deterministically determined by
the sequence context and flow order alone; in addition it will also depend on the
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nucleotide incorporation probability. Under incomplete nucleotide incorporation
conditions, the same template sequence will potentially generate many different
signals. This kind of combinatorial explosion makes the question of studying
the sequence length distribution more complicated than under the complete nu-
cleotide incorporation conditions. There are, however, mathematics tools that can
solve the problem nicely, and the solutions to both complete incorporation and
incomplete incorporation are united, with the former being a special case of the
latter.
1.2 Fixed sequence length model and fixed flow cycle model
1.2.1 Fixed sequence length model (FSLM)
Two models can be used to investigate various statistic distributions of SBS. One
model, which was used in our previous work, can be termed as fixed sequence
length model (FSLM). In this model the length of the template DNA sequences is
pre-defined as n. Thus, with 4 possible bases at each position, the total number of
sequences for a given n is 4n.
For FSLM with a given sequence length n, the minimum number of nucleotide
flows is 1, for a stretch of n a’s. The maximum number of nucleotide flows under
complete nucleotide incorporation conditions is 3n+1, for sequence dcbadcba....
In this case the maximum flow cycle is f = ⌈(3n+ 1)/4⌉. Thus for a fixed se-
quence length n, the range of flow cycle f is [1,⌈(3n+ 1)/4⌉]. For incomplete
nucleotide incorporation conditions, the upper limit of the range is determined by
the nucleotide incorporation probabilities.
Within this model, we have derived the generating function (GF) for Li(n, f ),
the probability that a sequence of length n and ending with nucleotide i, i =
a,b,c,d, is synthesized in the first f flow cycles, with the n-th nucleotide being
synthesized in flow cycle f . With the assumption that the nucleotides in the target
sequence are independent random variables with probabilities pa, pb, pc, and pd ,
and under complete nucleotide incorporation conditions, the first few values of
Li(n, f ) are shown in Table 1. Here and in the following the tables are arranged
so that each row is for a given sequence length n, and every four columns are for
a given flow cycle f , with each of the four columns within a given flow cycle f
corresponding to the nucleotide synthesized, in the order of a, b, c, d. As we have
shown, each row in Table 1 sums to 1,
∞
∑
f=1
∑
i∈{a,b,c,d}
Li(n, f ) = 1,
5
Table 1: The first few values of Li(n, f ) for fixed sequence length model (FSLM)
for complete nucleotide incorporation case. This model is used previously but
not in this paper. The recursive structure of Li(n, f ) is readily evident. Here
Ld(2,1) = (pa + pb + pc + pd)pd = pd . For each row, the sum of Li(n, f ) is 1:
∑∞f=1 ∑i∈{a,b,c,d}Li(n, f ) = 1.
f = 1 f = 2
n a b c d a b c d
1 pa pb pc pd 0 0 0 0
2 p2a (pa + pb)pb (pa + pb + pc)pc pd (pb + pc + pd)pa (pc + pd)pb pd pc 0
so for FSLM, Li(n, f ) is the probability over the flow cycle f for a fixed sequence
length n.
The value of Li(n, f ) gives the probability that for a given sequence length
n , the sequence can be sequenced in f flow cycles with the last base as i. The
more interesting question, the answer to which will have more practical uses, is
the distribution of sequence length for a given flow cycle f . To get the answer
to this question we have to look at the columns in Table 1 instead of rows. The
sum of the entries for each column (fixed f ) in Table 1, or every four columns
within each f , however, does not add up to 1, so we have to normalize the entries
to transform them into probabilities. For FSLM, only approximate closed form
normalization factors can be found, though the errors of the approximation are
small and become negligible when f becomes bigger.
This somewhat unsatisfactory detour motivated us to develop a model that
directly yields the distribution of sequence length for a fixed number f of flow
cycles. The model, fixed flow cycle model (FFCM), is the main focus of this
paper.
1.2.2 Fixed flow cycle model (FFCM)
In this model, instead of fixing the sequence length, we fix the number of flow
cycles. We assume that the sequence is generated by a random process that can
create sequences with infinite length, only the first part of which will be sequenced
by f flow cycles. In other words, for a fixed number f of flow cycles, we assume
that the target sequence is always longer than that can be sequenced by f cycles.
We also assume that the flow cycle f is always a complete cycle (i.e., the number
of nucleotide cycles is always a multiple of 4). With FFCM, the size of sample
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space becomes infinite. For example, for f = 1, the sequence ba... can only
get the first base b sequenced, while the hypothetical sequence bbbbbb... can in
theory get infinite read length for the first cycle. Hence for f = 1, in the first case
the sequence length n = 1, while for the second case the sequence length n → ∞.
We’re interested in the probability distribution of the sequence length n for a given
f .
1.3 Simulations
For FSLM, there are a finite number of sequences (4n for sequence length n). Un-
der complete nucleotide incorporation conditions, the range of flow cycle is also
finite (see subsection 1.2.1), so the sample space is finite. The analytical results
can be checked by enumeration over all possible points in this space. Indeed, all
results previously obtained for FSLM have been checked by enumerations. For
FFCM, however, the sample space is infinite, and we cannot enumerate all possi-
ble configurations in its sample space. To check the analytical results of FFCM
developed in this paper, we developed a simulation program written in C program-
ming language. The program can be found in http://graphics.med.yale.edu/sbs/.
All the results of this paper have been carefully checked against simulation results.
1.4 Notation and Definitions
As mentioned above, we use a, b, c, and d to represent any permutations of
the usual nucleotides A, C, G, and T to avoid the unnecessary specification of
the detailed names of the four kinds of nucleotides. The probabilities for the
four nucleotides in the target sequence are denoted as pa, pb, pc, and pd , with
∑i∈{a,b,c,d} pi = 1. We assume that the nucleotides in the target sequence are in-
dependent of each other. We always use f for the number of flow cycles, and n
as the length of sequenced reads. To avoid extra symbols, we often use the bases
themselves when their complements should be used, if no ambiguity arises. For
example, if the base in the template to be sequenced is b, then it’s the complement
of b that can be added chemically, but we will still use b instead of the complement
of b in the following developments.
The nucleotide incorporation probabilities are denoted as α(i)j , where i = a, b,
c, and d stands for the type of nucleotides, j = 0, 1, 2, . . . denotes the delayed flow
cycle number, with the current flow cycle as 0. The value of α(i)j is the probability
that the next nucleotide of type i will be incorporated in the j-th cycle from the
current flow cycle. For example, when it is complementary to the template, if the
chance for nucleotide b to be incorporated in the current cycle, the next cycle, and
the next-next cycle is 1/3, 1/2, and 1/6, respectively, then α(b)0 = 1/3, α
(b)
1 = 1/2,
α
(b)
2 = 1/6, and α
(b)
j = 0 for j > 2. The complete incorporation situation is a
special case in this notation with α(i)0 = 1 and α
(i)
j = 0 for j > 0. By definition
∑∞j=0 α(i)j = 1. The GFs of piα(i)j is denoted by gi(x) (i = a, b, c, and d):
gi(x) = pi
∞
∑
j=0
α
(i)
j x
j. (1)
We note that when x = 1, gi(1) = pi. Also, for the complete incorporation situa-
tion, gi(x) = pi.
To extract coefficients from expansion of GFs, we use notation [xn] f (x) to
denote the coefficient of xn in the series of f (x) in powers of x.
In Table 2 the common notation used throughout the paper is summarized in
one place. Some of the detailed definitions will be deferred to the relevant sections
in the following.
2 Complete nucleotide incorporation
In this section the complete nucleotide incorporation conditions will be studied.
As we showed previously, the key to the solution of FSLM is the set of recur-
sive equations of Li(n, f ). The set of equations cannot be solved analytically, but
transforming them into GFs leads to exact solutions of these GFs. The recursive
structure is evident in the elements in Table 1.
For FFCM, let Pi(n, f ) denote the probability that f flow cycles will synthesize
a sequence of length of n and with the last incorporated nucleotide being i, and let
P(n, f )=∑i∈{a,b,c,d}Pi(n, f ) be the probability that in f flow cycles the sequenced
length is n. For this section only, with complete nucleotide incorporation condi-
tions, the sequence length n starts from 1, since in this case the probability P(n, f )
for n = 0 is zero. For the incomplete nucleotide incorporation case discussed later
in section 3, however, the probability to have n = 0 is nonzero, and the case of
n = 0 will be considered there.
With this definition, it is evident that we have the following simple equations
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Table 2: Summary of notation and definitions.
Definition Comments
f flow cycle f = 1,2, . . .
n sequence length n = 0,1, . . .
a, b, c, d any permutation of the 4 nu-
cleotides
pi nucleotide probability i = a,b,c,d
α
(i)
j nucleotide incorporation
probability of nucleotide type
i that the next nucleotide will
be incorporated in the j-th
cycle from the current cycle
i = a,b,c,d, j = 0,1, . . . ; ∑∞j=0 α(i)j = 1
ωi conditional factors of nu-
cleotide type i, for complete
nucleotide incorporation
i = a,b,c,d
ω(i)j conditional factors of nu-
cleotide type i, for incomplete
nucleotide incorporation
i = a,b,c,d, j = 0,1, . . .
Pi(n, f ) probability that f flow cycles
will synthesize a sequence of
length of n and with the last
incorporated nucleotide being
i
i = a,b,c,d
P(n, f ) sum of Pi(n, f ) P(n, f ) = ∑i∈{a,b,c,d}Pi(n, f )
Li(n, f ) probability that a sequence of
length n and ending with nu-
cleotide i is synthesized in the
first f flow cycles, with the
n-th nucleotide being synthe-
sized in flow cycle f
i = a,b,c,d
L(n, f ) sum of Li(n, f ) L(n, f ) = ∑i∈{a,b,c,d}Li(n, f )
gi(x) GF of piα(i)j gi(x) = pi ∑∞j=0 α(i)j x j
hi(x) GF of ω(i)j hi(x) = ∑∞j=0 ω(i)j x j
Gi(x) GF of Pi(n, f ) Gi(x,y) = ∑∞n=0 ∑∞f=1 Pi(n, f )x f yn
G (x) sum of Gi(x) G (x) = ∑i∈{a,b,c,d}Gi(x)
Gi(x) GF of Li(n, f ) Gi(x,y) = ∑∞n=0 ∑∞f=1 Li(n, f )x f yn
G(x) sum of Gi(x) G(x) = ∑i∈{a,b,c,d}Gi(x)
ei elementary symmetric func-
tions of pi
i = 1, · · · ,4, Eq. (6)
ti(x) elementary symmetric func-
tions of gi(x)
i = 1, · · · ,4, Eq. (18)
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Table 3: The first few values of Pi(n, f ) for fixed flow cycle model (FFCM) under
complete nucleotide incorporation conditions. Note the factors ωi when compared
with the entries Li(n, f ) in Table 1. These factors are listed in Eq. (3). For each f ,
the sum of the four columns of Pi(n, f ) is 1: ∑∞n=0 ∑i∈{a,b,c,d}Pi(n, f ) = 1.
f = 1 f = 2
n a b c d a b c d
1 paωa pbωb pcωc pdωd 0 0 0 0
2 p2aωa (pa + pb)pbωb (pa + pb + pc)pcωc pdωd 0 (pc + pd)pbωb pd pcωc 0
· · · · · · · · · · · · · · · · · · · · · · · · · · ·
to link the probabilities Li(n, f ) of FSLM and the probabilities Pi(n, f ) of FFCM:
Pa(n, f ) = 0, (2)
Pb(n, f ) = Lb(n, f )pa,
Pc(n, f ) = Lc(n, f )(pa+ pb),
Pd(n, f ) = Ld(n, f )(pa+ pb + pc).
The first part of Eq. (2) is true because the first f flow cycles can never synthesize
a sequence ending with a and of length n. Indeed, irrespective of the type of
the (n+1)-st nucleotide, it will always be synthesized in the same flow cycle so
the length cannot be n. The second part of Eq. (2) is true because if the first f
flow cycles are to synthesize a sequence of length n and ending with b, then the
first n nucleotides of the sequence must be synthesized in the first f flow cycles
(which happens with probability Lb(n, f )), and then no more nucleotide must be
synthesized in the f -th flow cycle (because otherwise the first f flow cycles will
synthesize more than n nucleotides). The latter in turn implies that the (n+1)-st
nucleotide of the sequence must be a, which happens with probability pa. The last
two parts of Eq. (2) are true for similar reasons.
The first few values of Pi(n, f ) are listed in Table 3. Note the factors ωi in
Pi(n, f ) of Table 3 when they’re compared with Li(n, f ) of Table 1. The four
conditional factors are
ωa = 0, ωb = pa, ωc = pa + pb, and ωd = pa + pb + pc. (3)
The equations of probabilities Pi(n, f ) and Li(n, f ) in Eq. (2) can then be trans-
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formed into relations between their GFs:
Ga(x,y) = 0, (4)
Gb(x,y) = Gb(x,y)pa,
Gc(x,y) = Gc(x,y)(pa + pb),
Gd(x,y) = Gd(x,y)(pa + pb + pc),
where Gi(x,y) is the bivariate GF of Pi(n, f ):
Gi(x,y) =
∞
∑
n=0
∞
∑
f=1
Pi(n, f )x f yn, i = a,b,c,d,
and Gi(x,y) is the bivariate GF of Li(n, f ):
Gi(x,y) =
∞
∑
n=0
∞
∑
f=1
Li(n, f )x f yn, i = a,b,c,d.
Since Gi(x,y)’s have been solved previously (Eqs. (4)-(7), Kong (2009a)), Gi(x,y)
can be easily obtained from Eq. (4):
Ga(x,y) = 0, (5)
Gb(x,y) =
papbxy
H
[
1− (pc + pd)(1− x)y+ pc pd(1− x)2y2
]
,
Gc(x,y) =
(pa + pb)pcxy
H
[1− pd(1− x)y] ,
Gd(x,y) =
(pa + pb + pc)pdxy
H
,
where
H = 1− y+ e2(1− x)y2− e3(1− x)2y3 + e4(1− x)3y4.
Here ei’s are elementary symmetric functions (ESFs) of nucleotide probabilities
pi:
e1 = pa + pb + pc + pd = 1, (6)
e2 = papb + pa pc + pa pd + pb pc + pb pd + pc pd ,
e3 = papb pc + pa pbpd + pa pc pd + pb pc pd ,
e4 = papb pc pd.
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We’re mainly interested in P(n, f ), the probability of read length as n for a
given flow cycle f . Since P(n, f ) is the sum of Pi(n, f )’s, the GF of P(n, f ),
G (x,y), is the sum of Gi(x,y)’s:
G (x,y) = ∑
i∈{a,b,c,d}
Gi(x,y) =
xy
H
[
e2 − e3(1− x)y+ e4(1− x)2y2
]
. (7)
In comparison, the G(x,y) of FSLM, which is the sum of Gi(x,y)’s, is given by
G(x,y) = xy
H
[1− e2(1− x)y+ e3(1− x)2y2 − e4(1− x)3y3].
Although G (x,y) and G(x,y) look similar to each other, G(x,y) is the probabil-
ity generating function (pgf) for FSLM where sequence length n is fixed, while
G (x,y) is the pgf of FFCM where flow cycle f is fixed. To check that P(n, f )
generated by GF in Eq. (7) is a probability distribution over n, we see that
G (x,1) =
x
1− x
= x+ x2 + x3 + · · · ,
so that ∑∞n=1 P(n, f ) = 1 for any f . On the other hand,
G(1,y) = y
1− y
= y+ y2 + y3 + · · · ,
so that ∑∞f=1 L(n, f ) = 1 for any n.
From Eq. (5) or Eq. (7) we can in principle calculate exactly Pi(n, f ) or P(n, f )
for any f and n. In Figure 1 the distribution of sequence length are shown for the
first 10 flow cycles ( f = 1,2, . . . ,10). The nucleotide composition probabilities
used here are pa = 1/3 = 0.3333, pb = 1/11 = 0.0909, pc = 100/231 = 0.4329,
and pd = 1/7 = 0.1429. The distribution is calculated from Eq. (7).
2.1 Mean and variance
From GF Eq. (7) the mean and variance of the sequence length distribution P(n, f )
at a given number of flow cycles f can be calculated:
n¯( f ) = [x f ] ∂G (x,y)∂y
∣∣
∣
∣
y=1
, (8a)
σ 2( f ) = [x f ] ∂
2G (x,y)
∂y2
∣
∣
∣∣
y=1
+ n¯( f )− n¯2( f ). (8b)
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Figure 1: The distribution of sequence length for the first 10 cycles ( f =
1,2, . . . ,10) with complete nucleotide incorporation. The nucleotide composi-
tion probabilities used here are pa = 1/3 = 0.3333, pb = 1/11 = 0.0909, pc =
100/231 = 0.4329, and pd = 1/7 = 0.1429. The distribution is calculated from
Eq. (7).
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To get closed form formulas for n¯( f ) and σ 2( f ), we note that x = 1 is a sin-
gularity in both ∂G (x,y)/∂y|y=1 and ∂ 2G (x,y)/∂y2
∣∣
y=1. The denominator of
Eq. (8a) has a (x−1)2 factor:
(x−1)2(e2− e3 + e4 +(e3 −2e4)x+ e4x2),
and the denominator of Eq. (8b) has a (x−1)3 factor:
(x−1)3(e2− e3 + e4 +(e3−2e4)x+ e4x2)2.
For both Eq. (8a) and Eq. (8b) x = 1 is the pole that has the smallest module. By
using only the principal part of the series expansion, we obtain the closed form
formulas for n¯( f ) and σ 2( f ) as
n¯( f )≈ f
e2
+
e3
e22
−1, (9)
and
σ 2( f )≈ e2 +2e3 −3e
2
2
e32
f − e
2
2e3 −5e23 +4e2e4
e42
. (10)
When these formulas are compared with the corresponding closed form formulas
of FSLM (Eq. (20) and Eq. (21), Kong (2009a)), we see that again both the mean
and variance are linear functions of f . Furthermore, the coefficients of f are the
same in both models. The only differences are in the constant terms.
For the special case of equal base probability where pa = pb = pc = pd = 1/4,
we have
n¯( f )≈ 83 f −
5
9 ,
σ 2( f )≈ 40
27
f + 2081 .
In Table 4 the differences between the approximate and exact values of the
mean (Eq. (9)) and the variance (Eq. (10)) are shown for the first few values of
f , with the same parameters of nucleotide probabilities as those in Figure 1. The
exact values are calculated from Eq. (8a) and Eq. (8b). As we can see, the ap-
proximations are very good: for flow cycle as small as f = 5 the approximate and
exact values are already very close.
In Figure 2 the distribution of sequence length P(n, f ) with complete nu-
cleotide incorporation for flow cycle f = 100 is shown, together with a normal
14
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Figure 2: The distribution of sequence length with complete nucleotide incorpo-
ration for a fixed flow cycle of f = 100. The nucleotide composition probabilities
used here are the same as in Figure 1. The exact distribution is plotted as ’+’
and is calculated from Eq. (7). The continuous curve is the normal distribution
N(n¯( f ),σ 2( f )) of the same mean and variance as those of the exact distribution,
where n¯( f ) and σ 2( f ) are calculated from Eqs. (9) and (10). The normal distri-
bution shown here is N(296.6452,221.4998).
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Table 4: Comparisons of the closed form approximations and exact values of
the mean (Eq. (9)) and the variance (Eq. (10)) for the first few values of f , with
the same parameters as those in Figure 1. The exact values are calculated from
Eq. (8a) and Eq. (8b).
n¯( f ) σ 2( f )
f Eq. (9) exact mean Eq. (10) exact variance
1 2.35859351 2.39446565 2.37546292 2.25930624
2 5.33118557 5.32877823 4.58883999 4.60388485
3 8.30377762 8.30387577 6.80221706 6.80137770
4 11.27636968 11.27637169 9.01559413 9.01555228
5 14.24896173 14.24896084 11.22897120 11.22898734
6 17.22155379 17.22155390 13.44234827 13.44234604
7 20.19414585 20.19414584 15.65572534 15.65572555
8 23.16673790 23.16673790 17.86910241 17.86910240
9 26.13932996 26.13932996 20.08247948 20.08247948
10 29.11192201 29.11192201 22.29585655 22.29585655
distribution with the same mean and variance. The nucleotide composition prob-
abilities used here are the same as in Figure 1. The exact distribution is plotted as
’+’ and is calculated from Eq. (7). The continuous curve is the normal distribution
N(n¯( f ),σ 2( f )) of the same mean and variance as those of the exact distribution
P(n, f ), where n¯( f ) and σ 2( f ) are calculated from Eqs. (9) and (10). The normal
distribution shown in Figure 2 is N(296.6452,221.4998). As Figure 2 shows, the
normal distribution fits the distribution of P(n, f ) quite well, with the exact dis-
tribution slightly skews to the left and has a slightly thick tail on the right. The
approximate normality of the number of nucleotides synthesized over f flow cy-
cles is not surprising if we make a central limit theorem type of argument. This
number is the sum of the number of nucleotides synthesized in each of the f
flow cycles. Although these numbers are not independent (because the number
of nucleotides synthesized in the ( f + 1)-st cycle depends on the last nucleotide
incorporated in the f -th cycle), this dependence is weak and hence the sum will
converge to a normal distribution when f increases.
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3 Incomplete nucleotide incorporation
For the case of incomplete nucleotide incorporation, where probabilistically the
nucleotides may or may not be incorporated in a given nucleotide flow cycle based
on the enzyme reaction conditions, the relations become more complicated. In the
following we will express the probability Pi(n, f ) of FFCM for the case of incom-
plete nucleotide incorporation in terms of Li(n, f ), the probability of FSLM under
incomplete nucleotide incorporation conditions. We should emphasize that in the
following, both Pi(n, f ) and Li(n, f ) refer to the case of incomplete nucleotide in-
corporation. The expression of Li(n, f ) in the following is not the same as that
used in section 2, but rather that obtained in Kong (2009b). The nucleotide in-
corporation is now based on the nucleotide incorporation probabilities α(i)j , and
some flow cycles may be skipped for the incorporation. For Li(n, f ), however, it’s
still required that the n-th nucleotide be synthesized in flow cycle f , as required
by FSLM.
3.1 Relation between Pi(n, f ) and Li(n, f )
To establish the relation between Pi(n, f ) and Li(n, f ), we define events
Ai(n, f ) = the first n nucleotides of the sequence are synthesized in
the first f flow cycles, with the n-th nucleotide, of type i,
being synthesized in flow cycle f ;
Bi( j, f ) = following a synthesis of a nucleotide of type i in flow
cycle f − j, no more nucleotides are synthesized in flow
cycles f − j, f − j+1, . . . , f .
Then, with P denoting probability, Li(n, f ) = P(Ai(n, f )), and, formally by the
law of total probability,
Pi(n, f ) =
f−1
∑
j=0
P(Ai(n, f − j))P(Bi( j, f )) =
f−1
∑
j=0
Li(n, f − j)P(Bi( j, f )). (11)
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Furthermore the probabilities P(Bi( j, f )), which we denote by ω(i)j , can be ex-
pressed as
ω
(a)
j = pa(1−
j
∑
k=0
α
(a)
k )+ pb(1−
j
∑
k=0
α
(b)
k )+ pc(1−
j
∑
k=0
α
(c)
k )+ pd(1−
j
∑
k=0
α
(d)
k ),
(12)
ω
(b)
j = pa(1−
j−1
∑
k=0
α
(a)
k )+ pb(1−
j
∑
k=0
α
(b)
k )+ pc(1−
j
∑
k=0
α
(c)
k )+ pd(1−
j
∑
k=0
α
(d)
k ),
ω
(c)
j = pa(1−
j−1
∑
k=0
α
(a)
k )+ pb(1−
j−1
∑
k=0
α
(b)
k )+ pc(1−
j
∑
k=0
α
(c)
k )+ pd(1−
j
∑
k=0
α
(d)
k ),
ω
(d)
j = pa(1−
j−1
∑
k=0
α
(a)
k )+ pb(1−
j−1
∑
k=0
α
(b)
k )+ pc(1−
j−1
∑
k=0
α
(c)
k )+ pd(1−
j
∑
k=0
α
(d)
k ).
The first part of Eq. (12) is true because if the nucleotide synthesized in flow cycle
f − j is of type a, then the probability that no nucleotide of type i is incorporated
in flow cycles f − j, f − j + 1, . . . , f is pi(1−∑ jk=0 α(i)k ), irrespective of the nu-
cleotide type i. The second part of Eq. (12) is true because after a nucleotide of
type b is synthesized in flow cycle f − j, if the next nucleotide is of type a, it
cannot be synthesized in flow cycle f − j. The probability that it is not incorpo-
rated in flow cycles f − j + 1, f − j + 2, . . . , f is pa(1−∑ j−1k=0 α(a)k ). If the next
nucleotide is of type i ∈ {b,c,d}, then the probability that it is not incorporated
in flow cycles f − j, f − j + 1, . . . , f is pi(1−∑ jk=0 α(i)k ). The last two parts of
Eq. (12) are true for similar reasons.
Eq. (12) can be written in a more compact form as
ω
(a)
j = 1− (pa
j
∑
k=0
α
(a)
k + pb
j
∑
k=0
α
(b)
k + pc
j
∑
k=0
α
(c)
k + pd
j
∑
k=0
α
(d)
k ), (13)
ω
(b)
j = ω
(a)
j + paα
(a)
j ,
ω
(c)
j = ω
(b)
j + pbα
(b)
j ,
ω
(d)
j = ω
(c)
j + pcα
(c)
j .
For the case of complete incorporation, we have α(i)0 = 1 and α
(i)
j = 0, j > 0, so
ω
(i)
0 reduces to the factors ωi listed in Eq. (3) while ω(i)j = 0 for j > 0.
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3.1.1 The special case of n = 0
For incomplete incorporation, it’s possible that for a given flow cycle f , not a
single base is synthesized, i.e., n = 0. This case will never occur in the complete
incorporation situation. By slightly extending the definition of ω(a)j described
above, we can have for n = 0 and any f > 1,
Pa(0, f ) = ω(a)f−1,
Pb(0, f ) = 0,
Pc(0, f ) = 0,
Pd(0, f ) = 0.
3.2 Solution of Pi(n, f )
From Eq. (11) we see that the probabilities of FFCM and FSLM have the follow-
ing convolution relation:
Pi(n, f ) =
f−1
∑
j=0
Li(n, f − j)ω(i)j , i = a,b,c,d. (14)
Since Li(n, f ) has been solved (Kong, 2009b) and ω(i)j is a function of pi and α(i)j
(Eq. (12)), in principle we can calculate Pi(n, f ) from Eq. (14). To gain insight
into Pi(n, f ), however, we would like to get the GF of Pi(n, f ). The convolution
relations in Eq.(14) transform directly to products of GFs (Wilf, 2006). Before we
transform Eq.(14) into GFs, we first define and calculate the GF of ω(i)j .
3.2.1 Generating function of ω(i)j
If we define the GF of ω(i)j , j = 0,1,2, . . . , as
hi(x) =
∞
∑
j=0
ω
(i)
j x
j, i = a,b,c,d,
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and using the fact that the GF of pi ∑ jk=0 α
(i)
k is gi/(1−x) (Wilf, 2006), then from
Eq. (12) or Eq. (13) we obtain hi(x) as
ha(x) =
1− (ga +gb +gc +gd)
1− x
, (15)
hb(x) = ha(x)+ga(x) =
1− (xga +gb +gc +gd)
1− x
,
hc(x) = hb(x)+gb(x) =
1− (xga + xgb +gc +gd)
1− x
,
hd(x) = hc(x)+gc(x) =
1− (xga + xgb + xgc +gd)
1− x
,
where gi(x) is the GF of the nucleotide incorporation probabilities α(i)j (times pi)
of nucleotide type i, as defined in Eq. (1). For the complete incorporation case,
gi(x) = pi, and hi(x)’s reduce to
ha = 0, (16)
hb = pa,
hc = pa + pb,
hd = pa + pb + pc,
which agree with the factors ωi in Eq. (3).
3.2.2 GF solution of Pi(n, f )
Since Li(n,0) = 0, from the relation between Pi(n, f ) and Li(n, f ) of Eq. (14) we
have
Ga(x,y) = Ga(x,y)ha(x)+ xha(x), (17)
Gb(x,y) = Gb(x,y)hb(x),
Gc(x,y) = Gc(x,y)hc(x),
Gd(x,y) = Gd(x,y)hd(x).
The term xha(x) in Ga(x,y) takes into account of the fact that Pa(0, f ) = ω(a)f−1
and we count f from 1 while ω(i)j starts from j = 0. We already solved Gi(x,y)
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previously as (Kong, 2009b)
Ga(x,y) =
gaxy
H
F,
Gb(x,y) =
gbxy
H
[
1− (gc+gd)(1− x)y+gcgd(1− x)2y2
]
,
Gc(x,y) =
gcxy
H
[1−gd(1− x)y] ,
Gd(x,y) =
gdxy
H
,
where
H = 1− t1y+ t2(1− x)y2− t3(1− x)2y3 + t4(1− x)3y4,
and
F = [1−(gb+gc+gd)(1−x)y+(gbgc+gbgd+gcgd)(1−x)2y2−gbgcgd(1−x)3y3].
Here ti(x)’s are elementary symmetric functions (ESFs) of gi(x)’s, the GFs of the
nucleotide incorporation probabilities:
t1(x) = ga +gb +gc +gd, (18)
t2(x) = gagb +gagc +gagd +gbgc +gbgd +gcgd,
t3(x) = gagbgc +gagbgd +gagcgd +gbgcgd,
t4(x) = gagbgcgd.
Based on Eq. (16), we see that Gi(x,y) in Eq. (17) reduces to Eq. (4) for the
complete incorporation case.
Substitutions of Gi(x,y) into Eq (17) leads to the main result we are after:
G (x,y) =
x[1− t1 + t2(1− x)y− t3(1− x)2y2 + t4(1− x)3y3]
(1− x)[1− t1y+ t2(1− x)y2 − t3(1− x)2y3 + t4(1− x)3y4]
. (19)
This result is to be compared with the GF of L(n, f ) from FSLM:
G(x,y) = xy[t1− t2(1− x)y+ t3(1− x)
2y2 − t4(1− x)3y3]
1− t1y+ t2(1− x)y2− t3(1− x)2y3 + t4(1− x)3y4
.
To check that Pi(n, f ) is a probability distribution function over n, we put y = 1
into Eq. (19) to have
G (x,1) = x
1− x
= x+ x2 + · · · ,
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Figure 3: The distribution of sequence length for the first 10 cycles ( f =
1,2, . . . ,10) with incomplete nucleotide incorporation. The nucleotide composi-
tion probabilities used here are the same as in Figure 1. The hypothetical non-
zero nucleotide incorporation probabilities are α(a)j = [6/55,1/2,3/10,1/11],
α
(b)
j = [19/60,1/4,1/3,1/10], α
(c)
j = [407/630,1/7,1/10,1/9], and α
(d)
j =
[17/40,1/5,1/4,1/8]. The distribution is calculated from Eq. (19).
so the sum over n of values P(n, f ) for a fixed number f of flow cycles add up to
1: ∑∞n=0 P(n, f ) = ∑∞n=0 ∑i∈{a,b,c,d}Pi(n, f ) = 1. In contrast,
G(1,y) = y
1− y
= y+ y2 + · · · .
The distributions of sequence length for the first 10 flow cycles ( f = 1,2, . . . ,10)
with incomplete nucleotide incorporation are show in Figure 3. The nucleotide
composition probabilities used are pa = 1/3 = 0.3333, pb = 1/11= 0.0909, pc =
100/231 = 0.4329, and pd = 1/7 = 0.1429, the same as those used for complete
nucleotide incorporation case, such as Figure 1. The hypothetical non-zero nu-
cleotide incorporation probabilities used are α(a)j = [6/55,1/2,3/10,1/11], α
(b)
j =
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[19/60,1/4,1/3,1/10], α(c)j = [407/630,1/7,1/10,1/9], and α
(d)
j = [17/40,1/5,1/4,1/8],
for j = 0, 1, 2, and 3. For j > 3, α(i)j = 0. The distribution is calculated from
Eq. (19). These distributions can be compared with those in Figure 1 of complete
nucleotide incorporation conditions.
3.3 Mean and variance
From the GF G (x,y) we can obtain closed form expressions of the mean and
variance of the sequence length distribution using Eq. (8a) and Eq. (8b). Since
t1(1) = 1, the denominator of ∂G (x,y)/∂y|y=1 has a (x−1)2 factor, and the de-
nominator of ∂ 2G (x,y)/∂y2
∣
∣
y=1 has a (x−1)
3 factor. Again x = 1 is the pole that
has the smallest module. Using the principal part of the series expansion, we get
the closed form expression of the mean and variance of P(n, f ) as
n¯( f )≈ f
u
−
2e22−2e3 +4e2t ′1+2(t ′1)2− t ′′1 −2t ′2
2u2
, (20)
and
σ 2( f )≈ v− (3e2 + t
′
1−1)u
u3
f + w
12u4
, (21)
where
u = e2 + t
′
1,
v = 2e3 + t ′′1 +2t ′2,
w = 6uv(3u−4e2)+15v2−8u[3u(t ′2+ t ′′1 )+6t ′3+ t
(3)
1 +3t
′′
2 +6e4].
Here we use the abbreviations t ′i to denote t ′i(1), t ′′i as t ′′i (1) = ∂ 2ti(x)/∂x2|x=1,
etc.
From Eq. (20) and Eq. (21) we see that both mean and variance are linear
function of f . The coefficients of f are the same for both FFCM and FSLM
(Eq. (17a) and Eq. (17b) of Ref. Kong (2009b)). Only the constant terms differ
between the two models.
In Table 5 comparisons of the closed form approximations of the mean (Eq. (20))
and the variance (Eq. (21)) against their respective exact values for the first few
values of f are shown, with the same parameters as those in Figure 3. The exact
values are calculated from Eq. (19) using Eq. (8a) and Eq. (8b). We can see that
the closed form approximations are quite close to the exact values. As f increases,
the errors become smaller; when f reaches f = 8, the errors become negligible.
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Table 5: Comparisons of the closed form approximations of the mean (Eq. (20))
and the variance (Eq. (21)) against their respective exact values for the first few
values of f , with the same parameters as those in Figure 3. The exact values are
calculated from Eq. (19) using Eq. (8a) and Eq. (8b).
n¯( f ) σ 2( f )
f Eq. (20) exact mean Eq. (21) exact variance
1 0.43744094 0.57921752 0.82083681 0.72850788
2 1.17769743 1.16602712 1.29206252 1.30509385
3 1.91795391 1.89883904 1.76328823 1.80247850
4 2.65821039 2.68250622 2.23451393 2.15175889
5 3.39846688 3.39672794 2.70573964 2.71085442
6 4.13872336 4.13533479 3.17696535 3.19335924
7 4.87897985 4.88027760 3.64819106 3.64210312
8 5.61923633 5.61927551 4.11941677 4.11866116
9 6.35949281 6.35913945 4.59064248 4.59319956
10 7.09974930 7.09989881 5.06186819 5.06080288
11 7.84000578 7.84002311 5.53309389 5.53286474
12 8.58026226 8.58022040 6.00431960 6.00472717
13 9.32051875 9.32053270 6.47554531 6.47541913
14 10.06077523 10.06077853 6.94677102 6.94672379
15 10.80103172 10.80102741 7.41799673 7.41804782
16 11.54128820 11.54128938 7.88922244 7.88920999
17 12.28154468 12.28154513 8.36044814 8.36044095
18 13.02180117 13.02180070 8.83167385 8.83168045
19 13.76205765 13.76205775 9.30289956 9.30289844
20 14.50231414 14.50231420 9.77412527 9.77412416
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Figure 4: The distribution of sequence length with incomplete nucleotide incor-
poration for a fixed flow cycle of f = 100. The nucleotide composition prob-
abilities and the nucleotide incorporation probabilities used here are the same
as in Figure 3. The exact distribution is plotted as ’+’ and is calculated from
Eq. (19). The continuous curve is the normal distribution N(n¯( f ),σ 2( f )) of the
same mean and variance as those of the exact distribution, where n¯( f ) and σ 2( f )
are calculated from Eqs. (20) and (21). The normal distribution shown here is
N(73.7228,47.4722).
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Figure 5: The distributions of sequence length for a fixed flow cycle of f = 100
for complete and incomplete nucleotide incorporation. The curve on the right
is for complete nucleotide incorporation, the curve on the left is for incomplete
nucleotide incorporation. The nucleotide composition probabilities and the nu-
cleotide incorporation probabilities are the same as in Figure 2 and Figure 4.
Figure 4 shows the distribution of sequence length with incomplete nucleotide
incorporation for a fixed flow cycle of f = 100. The parameters used here are
the same as in Figure 3. The exact distribution is plotted as ’+’ and is calculated
from Eq. (19). The continuous curve is the normal distribution N(n¯( f ),σ 2( f ))
of the same mean and variance as those of the exact distribution, where n¯( f ) and
σ 2( f ) are calculated from Eqs. (20) and (21). The normal distribution shown
here is N(73.7228,47.4722). The agreement of the exact distribution with normal
distribution is decent, with a slight skew to the left.
For comparison, the distributions of sequence length with complete and in-
complete nucleotide incorporation for a fixed flow cycle of f = 100 are shown in
the same plot in Figure 5. The nucleotide composition probabilities and the nu-
cleotide incorporation probabilities are the same as those in Figure 2 and Figure 4.
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The delays of synthesis in the incomplete incorporation case shift the mean of the
sequence length distribution to the left, with a smaller variance.
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